Maplight Therapeutics, Inc. · NASDAQ:MPLT
Kroeger Christopher A. sold 73,691 Maplight Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 73,691 Maplight Therapeutics, Inc. shares at US$8.08 for US$595K, leaving 1,195,909 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 73,691 shares
- Price
- US$8.08
- Value
- US$595K
- Holding after
- 1,195,909 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Voting Common Stock | Sale | 73,691 | US$8.08 | 1,195,909 | Direct |
Source
Download original · View original at SEC
Related
- Maplight Therapeutics, Inc.
- Kroeger Christopher A.
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Kroeger Christopher A. · Aug 19, 2026
- Form 4 · Kroeger Christopher A. · Jul 17, 2026
- Form 4 · Kroeger Christopher A. · May 18, 2026
- Form 4 · Kroeger Christopher A. · May 11, 2026
- Form 4 · Kroeger Christopher A. · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026